Market Cap 8.65B
Revenue (ttm) 570.40M
Net Income (ttm) 223.19M
EPS (ttm) N/A
PE Ratio 39.78
Forward PE 45.24
Profit Margin 39.13%
Debt to Equity Ratio 0.00
Volume 7,003,300
Avg Vol 1,841,704
Day's Range N/A - N/A
Shares Out 188.27M
Stochastic %K 10%
Beta 1.38
Analysts Sell
Price Target $68.53

Company Profile

Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The company primarily serves physicians, nurse practitioners, physician assistants...

Industry: Health Information Services
Sector: Healthcare
Phone: 650 549 4330
Address:
500 3rd Street, Suite 510, San Francisco, United States
high_tech_texan
high_tech_texan Dec. 6 at 10:27 PM
$DOCS Looks oversold - thinking about dipping my toe in here Monday.
0 · Reply
RunnerSignals
RunnerSignals Dec. 6 at 6:04 PM
$BRX $DOCS $MSI $SIG $SMA oversold alert! Contrarian traders take note these might bounce soon https://stocksrunner.com/news/2025-12-06-daily-market-pulse-insights-reveal-advanced-technical-trends
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 2:30 AM
Actionable Trade Alert for $DOCS: Market Context: $DOCS is currently trading at $51.31, showing a neutral to bullish sentiment given the RSI of 55.94, which indicates potential upward momentum. The stock is below its MA30 of 56.1 and significantly below its MA50 of 61.83, suggesting a recovery opportunity. Directional Bias: The current price is closer to the 60D low of 46.04 than the high of 76.51, indicating potential for an upward move. With the RSI nearing the mid-point, there’s room for growth before hitting overbought conditions. Trade Plan: - Suggested Entry: $51.31 - Stop Loss: $47.50 (approximately 7% below entry) - Take Profit Targets: 1. $56.00 (10% gain) 2. $60.00 (17% gain) 3. $60.00 (17% gain) The third target aligns with a substantial ROI, making this a strategic entry point for a bullish reversal. Monitor price action closely. https://privateprofiteers.com
0 · Reply
Arcides
Arcides Dec. 6 at 2:27 AM
$DOCS complete piece of shit, no news 3X+ average dump..
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 10:05 PM
Actionable Trade Alert for $DOCS: Market Context: $DOCS is currently trading at $51.31, showing a neutral to bullish sentiment given the RSI of 55.94, which indicates potential upward momentum. The stock is below its MA30 of 56.1 and significantly below its MA50 of 61.83, suggesting a recovery opportunity. Directional Bias: The current price is closer to the 60D low of 46.04 than the high of 76.51, indicating potential for an upward move. With the RSI nearing the mid-point, there’s room for growth before hitting overbought conditions. Trade Plan: - Suggested Entry: $51.31 - Stop Loss: $47.50 (approximately 7% below entry) - Take Profit Targets: 1. $56.00 (10% gain) 2. $60.00 (17% gain) 3. $60.00 (17% gain) The third target aligns with a substantial ROI, making this a strategic entry point for a bullish reversal. Monitor price action closely. https://privateprofiteers.com
0 · Reply
Walkadon
Walkadon Dec. 5 at 8:07 PM
$DOCS Buy after earnings and the lawsuits settle, and after the dust settles on whether big pharma will continue to buy ads at same scale, with the big shakeup in medical biz underway and the advent of Trump RX and others. Things are unclear right now, just like was warned in the recent earnings report.
0 · Reply
optioned
optioned Dec. 5 at 7:54 PM
$DOCS Doubling up here. This looks like someone exiting a large position, which obviously isn't a promising development. But in a stock with light volume the move lower is greatly exaggerated. Three month PT = bounce then fill the gap back up to $62
0 · Reply
StockHunter75
StockHunter75 Dec. 5 at 7:44 PM
$DOCS Calling bottom.
0 · Reply
StockHunter75
StockHunter75 Dec. 5 at 7:39 PM
$DOCS Time to buy.
2 · Reply
StockHunter75
StockHunter75 Dec. 5 at 7:25 PM
$DOCS Added a starter.
0 · Reply
Latest News on DOCS
Doximity, Inc. (DOCS) Q2 2026 Earnings Call Transcript

Nov 6, 2025, 8:56 PM EST - 4 weeks ago

Doximity, Inc. (DOCS) Q2 2026 Earnings Call Transcript


Doximity, Inc. (DOCS) Q1 2026 Earnings Call Transcript

Aug 7, 2025, 9:50 PM EDT - 4 months ago

Doximity, Inc. (DOCS) Q1 2026 Earnings Call Transcript


Doximity (DOCS) Q1 Revenue Rises 15%

Aug 7, 2025, 8:33 PM EDT - 4 months ago

Doximity (DOCS) Q1 Revenue Rises 15%


Doximity Acquires Pathway, a Leader in AI Clinical Reference

Aug 7, 2025, 4:02 PM EDT - 4 months ago

Doximity Acquires Pathway, a Leader in AI Clinical Reference


Doximity Announces Fiscal 2026 First Quarter Financial Results

Aug 7, 2025, 4:01 PM EDT - 4 months ago

Doximity Announces Fiscal 2026 First Quarter Financial Results


Doximity: Slowing Sales And EBITDA Growth

Jul 23, 2025, 3:35 PM EDT - 4 months ago

Doximity: Slowing Sales And EBITDA Growth


Doximity Crushes The Rule Of 40 - Try Rule Of 58

Jul 2, 2025, 10:36 AM EDT - 5 months ago

Doximity Crushes The Rule Of 40 - Try Rule Of 58


Doximity: A Closer Look at Its Investment Potential

May 20, 2025, 7:00 PM EDT - 7 months ago

Doximity: A Closer Look at Its Investment Potential


Doximity: Strong Growth but What's Next?

May 19, 2025, 9:04 AM EDT - 7 months ago

Doximity: Strong Growth but What's Next?


Doximity Stock 7.8% Higher After Key Trading Signal

May 19, 2025, 7:47 AM EDT - 7 months ago

Doximity Stock 7.8% Higher After Key Trading Signal


These Analysts Cut Their Forecasts On Doximity After Q4 Results

May 16, 2025, 1:51 PM EDT - 7 months ago

These Analysts Cut Their Forecasts On Doximity After Q4 Results


Why Doximity Stock Is Plummeting Today

May 16, 2025, 12:43 PM EDT - 7 months ago

Why Doximity Stock Is Plummeting Today


Doximity, Inc. (DOCS) Q4 2025 Earnings Call Transcript

May 15, 2025, 8:35 PM EDT - 7 months ago

Doximity, Inc. (DOCS) Q4 2025 Earnings Call Transcript


Doximity Stock Drops 20% After Outlook Disappoints

May 15, 2025, 5:55 PM EDT - 7 months ago

Doximity Stock Drops 20% After Outlook Disappoints


Doximity: Rating Downgrade As Near-Term Upside Is Priced In

Feb 14, 2025, 5:53 PM EST - 10 months ago

Doximity: Rating Downgrade As Near-Term Upside Is Priced In


Doximity Momentum, Big Money Support Stays Strong

Feb 14, 2025, 7:49 AM EST - 10 months ago

Doximity Momentum, Big Money Support Stays Strong


Doximity Q3 Earnings: Outpacing Even Management's Expectations

Feb 10, 2025, 12:04 PM EST - 10 months ago

Doximity Q3 Earnings: Outpacing Even Management's Expectations


Why Doximity Stock Skyrocketed Higher Today

Feb 7, 2025, 12:01 PM EST - 10 months ago

Why Doximity Stock Skyrocketed Higher Today


Doximity shares pop 30% on revenue beat, rosy guidance

Feb 7, 2025, 10:38 AM EST - 10 months ago

Doximity shares pop 30% on revenue beat, rosy guidance


Doximity, Inc. (DOCS) Q3 2025 Earnings Call Transcript

Feb 6, 2025, 8:01 PM EST - 10 months ago

Doximity, Inc. (DOCS) Q3 2025 Earnings Call Transcript


Doximity Surpasses EPS, Revenue Goals

Feb 6, 2025, 4:39 PM EST - 10 months ago

Doximity Surpasses EPS, Revenue Goals


Doximity Announces Fiscal 2025 Third Quarter Financial Results

Feb 6, 2025, 4:01 PM EST - 10 months ago

Doximity Announces Fiscal 2025 Third Quarter Financial Results


high_tech_texan
high_tech_texan Dec. 6 at 10:27 PM
$DOCS Looks oversold - thinking about dipping my toe in here Monday.
0 · Reply
RunnerSignals
RunnerSignals Dec. 6 at 6:04 PM
$BRX $DOCS $MSI $SIG $SMA oversold alert! Contrarian traders take note these might bounce soon https://stocksrunner.com/news/2025-12-06-daily-market-pulse-insights-reveal-advanced-technical-trends
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 2:30 AM
Actionable Trade Alert for $DOCS: Market Context: $DOCS is currently trading at $51.31, showing a neutral to bullish sentiment given the RSI of 55.94, which indicates potential upward momentum. The stock is below its MA30 of 56.1 and significantly below its MA50 of 61.83, suggesting a recovery opportunity. Directional Bias: The current price is closer to the 60D low of 46.04 than the high of 76.51, indicating potential for an upward move. With the RSI nearing the mid-point, there’s room for growth before hitting overbought conditions. Trade Plan: - Suggested Entry: $51.31 - Stop Loss: $47.50 (approximately 7% below entry) - Take Profit Targets: 1. $56.00 (10% gain) 2. $60.00 (17% gain) 3. $60.00 (17% gain) The third target aligns with a substantial ROI, making this a strategic entry point for a bullish reversal. Monitor price action closely. https://privateprofiteers.com
0 · Reply
Arcides
Arcides Dec. 6 at 2:27 AM
$DOCS complete piece of shit, no news 3X+ average dump..
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 10:05 PM
Actionable Trade Alert for $DOCS: Market Context: $DOCS is currently trading at $51.31, showing a neutral to bullish sentiment given the RSI of 55.94, which indicates potential upward momentum. The stock is below its MA30 of 56.1 and significantly below its MA50 of 61.83, suggesting a recovery opportunity. Directional Bias: The current price is closer to the 60D low of 46.04 than the high of 76.51, indicating potential for an upward move. With the RSI nearing the mid-point, there’s room for growth before hitting overbought conditions. Trade Plan: - Suggested Entry: $51.31 - Stop Loss: $47.50 (approximately 7% below entry) - Take Profit Targets: 1. $56.00 (10% gain) 2. $60.00 (17% gain) 3. $60.00 (17% gain) The third target aligns with a substantial ROI, making this a strategic entry point for a bullish reversal. Monitor price action closely. https://privateprofiteers.com
0 · Reply
Walkadon
Walkadon Dec. 5 at 8:07 PM
$DOCS Buy after earnings and the lawsuits settle, and after the dust settles on whether big pharma will continue to buy ads at same scale, with the big shakeup in medical biz underway and the advent of Trump RX and others. Things are unclear right now, just like was warned in the recent earnings report.
0 · Reply
optioned
optioned Dec. 5 at 7:54 PM
$DOCS Doubling up here. This looks like someone exiting a large position, which obviously isn't a promising development. But in a stock with light volume the move lower is greatly exaggerated. Three month PT = bounce then fill the gap back up to $62
0 · Reply
StockHunter75
StockHunter75 Dec. 5 at 7:44 PM
$DOCS Calling bottom.
0 · Reply
StockHunter75
StockHunter75 Dec. 5 at 7:39 PM
$DOCS Time to buy.
2 · Reply
StockHunter75
StockHunter75 Dec. 5 at 7:25 PM
$DOCS Added a starter.
0 · Reply
_www_larval_com_
_www_larval_com_ Dec. 5 at 6:22 PM
Dufus here, $DOCS just reversed 3% higher to -6% (~2Mv) moments ago, 12/19 options, follow for more volatility.
0 · Reply
BullYa
BullYa Dec. 5 at 6:22 PM
$DOCS 📉 $45?
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 4 at 2:52 PM
$DOCS Current Stock Price: $51.20 Contracts to trade: $50 DOCS Dec 19 2025 Call Entry: $2.16 Exit: $2.98 ROI: 38% Hold ~28 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
TeladocHub
TeladocHub Nov. 26 at 12:19 AM
$TDOC $HIMS $OSCR $UNH $DOCS You can copy a UI. You can’t copy: 🇺🇸 U.S. compliance 🇪🇺 EU regulatory alignment 🇬🇧 NHS contracts 🇨🇦 Provincial integration 🌏 Asia-Pacific distribution 🌍 20 years of global clinical data Good luck scaling that before 2040. ALL-IN TELADOC!
2 · Reply
TeladocHub
TeladocHub Nov. 24 at 5:06 PM
2 · Reply
rogergarrison
rogergarrison Nov. 24 at 1:26 PM
The market narrative is pivoting from 'will the Fed cut?' to 'what happens after the AI buildout is complete?' Focus on companies with sustainable revenue models after the initial infrastructure rush. That's the 2026 trade. $DOCS $ZETA $RBLX $RDDT
0 · Reply
Playthecasino
Playthecasino Nov. 23 at 1:48 PM
$DOCS Weekly chart with 2024 volume profile and developing 2025 profile. Price is at a reasonable spot for a swing low (if not "the" bottom. Reclaim 52ish (2025 value area low) could see it get back to 57. But, also will be watching 40-43ish (if seen).
0 · Reply
JarvisFlow
JarvisFlow Nov. 21 at 4:58 PM
Raymond James has adjusted their stance on Doximity ( $DOCS ), setting the rating to Strong Buy with a target price of 75 → 65.
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Nov. 21 at 4:17 PM
$DOCS I hate these - upgrades with lower price targets
0 · Reply
notreload_ai
notreload_ai Nov. 21 at 11:44 AM
Raymond James upgrades $DOCS to Strong Buy with a $65 target, citing an attractive risk/reward setup and improved long-term growth visibility despite a recent pullback. https://notreload.xyz/doximity-upgraded-to-strong-buy-by-raymond-james/
0 · Reply
theflynews
theflynews Nov. 21 at 10:01 AM
Doximity just upgraded at Raymond James, here's why - $DOCS - https://thefly.com/permalinks/entry.php/DOCSid4244127?1763719204C38
0 · Reply
StockHunter75
StockHunter75 Nov. 17 at 8:07 PM
$DOCS Added
0 · Reply